Acute and repeated intranasal oxytocin administration exerts anti-aggressive and pro-affiliative effects in male rats

Psychoneuroendocrinology

Volumn 51, Issue , 2015, Pages 112-121

  Calcagnoli, Federica ^a,b   Kreutzmann, Judith C ^a   de Boer, Sietse F ^a   Althaus, Monika ^b   Koolhaas, Jaap M ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Blood pressure; Heart rate; Intranasal application; Offensive behavior; Oxytocin; Partner preference; Social exploration

Indexed keywords

OXYTOCIN;

ADULT; AGGRESSION; ANALYSIS OF COVARIANCE; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BODY TEMPERATURE; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; HEART RATE; HORMONE ACTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOCOMOTION; MALE; NONHUMAN; RAT; SOCIAL BEHAVIOR; SOCIAL INTERACTION; TELEMETRY; ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECTS; FEMALE; INTRANASAL DRUG ADMINISTRATION;

ADMINISTRATION, INTRANASAL; AGGRESSION; ANIMALS; BEHAVIOR, ANIMAL; BLOOD PRESSURE; FEMALE; HEART RATE; MALE; OXYTOCIN; RATS; SOCIAL BEHAVIOR;

EID: 84917731888     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.09.019     Document Type: Article

References (54)

1. Bales K.L., Perkeybile A.M., Conley O.G., Lee M.H., Guoynes C.D., Downing G.M., Yun C.R., Solomon M., Jacob S., Mendoza S.P. Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles. Biol. Psychiatry 2013, 74:180-188.
2. Bernatova I., Rigatto K.V., Key M.P., Morris M. Stress-induced pressor and corticosterone responses in oxytocin-deficient mice. Exp. Physiol. 2004, 89:549-557.
3. Bertsch K., Gamer M., Schmidt B., Schmidinger I., Walther S., Kastel T., Schnell K., Buchel C., Domes G., Herpertz S.C. Oxytocin and reduction of social threat hypersensitivity in women with borderline personality disorder. Am. J. Psychiatry 2013, 170:1169-1177.
4. Born J., Lange T., Kern W., McGregor G.P., Bickel U., Fehm H.L. Sniffing neuropeptides: a transnasal approach to the human brain. Nat. Neurosci. 2002, 5:514-516.
5. Calcagnoli F., de Boer S.F., Althaus M., den Boer J.A., Koolhaas J.M. Antiaggressive activity of central oxytocin in male rats. Psychopharmacology (Berl.) 2013, 229:639-651.
6. Calcagnoli F., Meyer N., de Boer S.F., Althaus M., Koolhaas J.M. Chronic enhancement of brain oxytocin levels causes enduring anti-aggressive and pro-social explorative behavioral effects in male rats. Horm. Behav. 2014, 65:427-433.
7. Calcagnoli F., Stubbendorff C., Meyer N., de Boer S.F., Althaus M., Koolhaas J.M. Oxytocin microinjected into the central amygdaloid nuclei exerts anti-aggressive effects in male rats. Neuropharmacology 2014, (unpublished).
8. Campbell A., Hausmann M. Effects of oxytocin on women's aggression depend on state anxiety. Aggress Behav. 2013, 39:316-322.
9. Carson D.S., Hunt G.E., Guastella A.J., Barber L., Cornish J.L., Arnold J.C., Boucher A.A., McGregor I.S. Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addict. Biol. 2010, 15:448-463.
10. Chang S.W., Barter J.W., Ebitz R.B., Watson K.K., Platt M.L. Inhaled oxytocin amplifies both vicarious reinforcement and self reinforcement in rhesus macaques (Macaca mulatta). Proc. Natl. Acad. Sci. U. S. A. 2012, 109:959-964.
11. Cho M.M., DeVries A.C., Williams J.R., Carter C.S. The effects of oxytocin and vasopressin on partner preferences in male and female prairie voles (Microtus ochrogaster). Behav. Neurosci. 1999, 113:1071-1079.
12. Churchland P.S., Winkielman P. Modulating social behavior with oxytocin: how does it work? What does it mean?. Horm. Behav. 2012, 61:392-399.
13. de Boer S.F., van der Vegt B.J., Koolhaas J.M. Individual variation in aggression of feral rodent strains: a standard for the genetics of aggression and violence?. Behav. Genet. 2003, 33:485-501.
14. De Dreu C.K.W., Greer L.L., Van Kleef G.A., Shalvi S., Handgraaf M.J.J. Oxytocin promotes human ethnocentrism. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:1262-1266.
15. Declerck C.H., Boone C., Kiyonari T. Oxytocin and cooperation under conditions of uncertainty: the modulating role of incentives and social information. Horm. Behav. 2010, 57:368-374.
16. Dhuria S.V., Hanson L.R., Frey W.H. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J. Pharm. Sci. 2010, 99:1654-1673.
17. Dluzen D.E., Muraoka S., Engelmann M., Landgraf R. The effects of infusion of arginine vasopressin, oxytocin, or their antagonists into the olfactory bulb upon social recognition responses in male rats. Peptides 1998, 19:999-1005.
18. Domes G., Heinrichs M., Glascher J., Buchel C., Braus D.F., Herpertz S.C. Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol. Psychiatry 2007, 62:1187-1190.
19. Gossen A., Hahn A., Westphal L., Prinz S., Schultz R.T., Grunder G., Spreckelmeyer K.N. Oxytocin plasma concentrations after single intranasal oxytocin administration - a study in healthy men. Neuropeptides 2012, 46:211-215.
20. Guastella A.J., Einfeld S.L., Gray K.M., Rinehart N.J., Tonge B.J., Lambert T.J., Hickie I.B. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol. Psychiatry 2010, 67:692-694.
21. Guastella A.J., Hickie I.B., McGuinness M.M., Otis M., Woods E.A., Disinger H.M., Chan H.-K., Chen T.F., Banati R.B. Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research. Psychoneuroendocrinology 2013, 38:612-625.
22. Hall S.S., Lightbody A.A., McCarthy B.E., Parker K.J., Reiss A.L. Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome. Psychoneuroendocrinology 2012, 37:509-518.
23. Hicks C., Ramos L., Reekie T., Misagh G.H., Narlawar R., Kassiou M., McGregor I.S. Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats. Br. J. Pharmacol. 2014, 171:2868-2887.
24. Kirsch P., Esslinger C., Chen Q., Mier D., Lis S., Siddhanti S., Gruppe H., Mattay V.S., Gallhofer B., Meyer-Lindenberg A. Oxytocin modulates neural circuitry for social cognition and fear in humans. J. Neurosci. 2005, 25:11489-11493.
25. Kosfeld M., Heinrichs M., Zak P.J., Fischbacher U., Fehr E. Oxytocin increases trust in humans. Nature 2005, 435:673-676.
26. Le Moal M., Koob G.F., Koda L.Y., Bloom F.E., Manning M., Sawyer W.H., Rivier J. Vasopressor receptor antagonist prevents behavioural effects of vasopressin. Nature 1981, 291:491-493.
27. LeDoux J.E. Emotional memory: in search of systems and synapses. Ann. N. Y. Acad. Sci. 1993, 702:149-157.
28. Liu G.F., Lu K., Mogg R., Mallick M., Mehrotra D.V. Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials?. Stat. Med. 2009, 28:2509-2530.
29. Liu J.C., Guastella A.J., Dadds M.R. Exploring the role of intra-nasal oxytocin on the partner preference effect in humans. Psychoneuroendocrinology 2013, 38:587-591.
30. Ludwig M., Tobin V.A., Callahan M.F., Papadaki E., Becker A., Engelmann M., Leng G. Intranasal application of vasopressin fails to elicit changes in brain immediate early gene expression, neural activity and behavioural performance of rats. J. Neuroendocrinol. 2013, 25:655-667.
31. Lukas M., Neumann I.D. Nasal application of neuropeptide S reduces anxiety and prolongs memory in rats: social versus non-social effects. Neuropharmacology 2012, 62:398-405.
32. MacDonald E., Dadds M.R., Brennan J.L., Williams K., Levy F., Cauchi A.J. A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research. Psychoneuroendocrinology 2011, 36:1114-1126.
33. Maier T., Dai W.J., Csikos T., Jirikowski G.F., Unger T., Culman J. Oxytocin pathways mediate the cardiovascular and behavioral responses to substance P in the rat brain. Hypertension 1998, 31:480-486.
34. Modi M.E., Connor-Stroud F., Landgraf R., Young L.J., Parr L.A. Aerosolized oxytocin increases cerebrospinal fluid oxytocin in rhesus macaques. Psychoneuroendocrinology 2014, 45:49-57.
35. Naber F., van Ijzendoorn M.H., Deschamps P., van Engeland H., Bakermans-Kranenburg M.J. Intranasal oxytocin increases fathers' observed responsiveness during play with their children: a double-blind within-subject experiment. Psychoneuroendocrinology 2010, 35:1583-1586.
36. Neumann I.D., Maloumby R., Beiderbeck D.I., Lukas M., Landgraf R. Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice. Psychoneuroendocrinology 2013, 38:1985-1993.
37. Parker K.J., Buckmaster C.L., Schatzberg A.F., Lyons D.M. Intranasal oxytocin administration attenuates the ACTH stress response in monkeys. Psychoneuroendocrinology 2005, 30:924-929.
38. Pedersen C.A., Gibson C.M., Rau S.W., Salimi K., Smedley K.L., Casey R.L., Leserman J., Jarskog L.F., Penn D.L. Intranasal oxytocin reduces psychotic symptoms and improves theory of mind and social perception in schizophrenia. Schizophr. Res. 2011, 132:50-53.
39. Petersson M., Alster P., Lundeberg T., Uvnas-Moberg K. Oxytocin causes a long-term decrease of blood pressure in female and male rats. Physiol. Behav. 1996, 60:1311-1315.
40. Petrovic P., Kalisch R., Singer T., Dolan R.J. Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. J. Neurosci. 2008, 28:6607-6615.
41. Ramos L., Hicks C., Kevin R., Caminer A., Narlawar R., Kassiou M., McGregor I.S. Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor. Neuropsychopharmacology 2013, 38:2249-2259.
42. Ramos L., Hicks C., Caminer A., McGregor I.S. Inhaled vasopressin increases sociability and reduces body temperature and heart rate in rats. Psychoneuroendocrinology 2014, 46:46-51.
43. Sah P., Faber E.S.L., Lopez de Armentia M., Power J. The amygdaloid complex: anatomy and physiology. Physiol. Rev. 2003, 83:803-834.
44. Senn S. Change from baseline and analysis of covariance revisited. Stat. Med. 2006, 25:4334-4344.
45. Sokolowski K., Corbin J.G. Wired for behaviors: from development to function of innate limbic system circuitry. Front. Mol. Neurosci. 2012, 5:55.
46. Striepens N., Kendrick K.M., Hanking V., Landgraf R., Wullner U., Maier W., Hurlemann R. Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans. Sci. Rep. 2013, 3:3440.
47. Swanson L.W., Petrovich G.D. What is the amygdala?. Trends Neurosci. 1998, 21:323-331.
48. Thorne R.G., Pronk G.J., Padmanabhan V., Frey Ii W.H. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 2004, 127:481-496.
49. Van I.M.H., Bakermans-Kranenburg M.J. A sniff of trust: meta-analysis of the effects of intranasal oxytocin administration on face recognition, trust to in-group, and trust to out-group. Psychoneuroendocrinology 2012, 37:438-443.
50. Weisman O., Zagoory-Sharon O., Feldman R. Intranasal oxytocin administration is reflected in human saliva. Psychoneuroendocrinology 2012, 37:1582-1586.
51. Williams J.R., Insel T.R., Harbaugh C.R., Carter C.S. Oxytocin administered centrally facilitates formation of a partner preference in female prairie voles (Microtus ochrogaster). J. Neuroendocrinol. 1994, 6:247-250.
52. Yoshimura R., Kiyama H., Kimura T., Araki T., Maeno H., Tanizawa O., Tohyama M. Localization of oxytocin receptor messenger ribonucleic acid in the rat brain. Endocrinology 1993, 133:1239-1246.
53. Young K.A., Gobrogge K.L., Liu Y., Wang Z. The neurobiology of pair bonding: insights from a socially monogamous rodent. Front. Neuroendocrinol. 2011, 32:53-69.
54. Zak P.J., Stanton A.A., Ahmadi S. Oxytocin increases generosity in humans. PLoS ONE 2007, 2:e1128.